Anti-tumour and immunomodulating activities of diosgenin, a naturally occurring steroidal saponin

Natural Product Research

Volumn 26, Issue 23, 2012, Pages 2243-2246

  He, Zhongmei ^a,c   Tian, Yudan ^b   Zhang, Xiantao ^c   Bing, Bai ^c   Zhang, Lianxue ^a   Wang, Huaisheng ^d   Zhao, Wenjie ^d  

^a JILIN AGRICULTURAL UNIVERSITY   (China)

^b CHANGCHUN UNIVERSITY   (China)

^c Xiuzheng Pharmaceutical Group Company Limited   (China)

^d Jilin Tianyao Science and Technology Company Limited   (China)

Author keywords

anti tumour activity; diosgenin; immunomodulation; saponin

Indexed keywords

CYCLOPHOSPHAMIDE; DIOSGENIN; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CHEMOTHERAPY; CANCER INHIBITION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG CYTOTOXICITY; DRUG DOSE; DRUG DOSE COMPARISON; DRUG MECHANISM; HEMOLYSIS; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE TRANSFORMATION; MOUSE; NONHUMAN; ORGAN WEIGHT; PERITONEUM MACROPHAGE; PHAGOCYTOSIS; PROTEIN BLOOD LEVEL; SARCOMA 180; SPLEEN; SPLEEN WEIGHT; THYMUS; TUMOR CELL; TUMOR GROWTH;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL LINE, TUMOR; CELL PROLIFERATION; DIOSGENIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EVALUATION, PRECLINICAL; IMMUNOLOGIC FACTORS; LYMPHOCYTES; MACROPHAGE ACTIVATION; MACROPHAGES, PERITONEAL; MICE; ORGAN SIZE; PHAGOCYTOSIS; SARCOMA 180; SPLEEN; THYMUS GLAND; TUMOR NECROSIS FACTOR-ALPHA;

MUS;

EID: 84868132557     PISSN: 14786419     EISSN: 14786427     Source Type: Journal    
DOI: 10.1080/14786419.2011.648192     Document Type: Article

References (11)

1. Chen, P.S., Shih, Y.W., Huang, H.C., & Cheng, H.W. (2011). Diosgenin, a steroidal saponin, inhibits migration and invasion of human prostate cancer PC-3 cells by reducing matrix metalloproteinases expression. PLoS One, 6, e20164.
2. Kang, K.A., Kang, J.H., & Yang, M.P. (2008). Ginseng total saponin enhances the phagocytic capacity of canine peripheral blood phagocytes in vitro. American Journal of Chinese Medicine, 36, 329-341. (Pubitemid 351712439)
3. Kukhetpitakwong, R., Hahnvajanawong, C., Homchampa, P., Leelavatcharamas, V., Satra, J., & Khunkitti, W. (2006). Immunological adjuvant activities of saponin extracts from the pods of Acacia concinna. International Immunopharmacology, 6, 1729-1735.
4. Li, F., Fernandez, P.P., Rajendran, P., Hui, K.M., & Sethi, G. (2010). Diosgenin, a steroidal saponin, inhibits STAT3 signaling pathway leading to suppression of proliferation and chemosensitization of human hepatocellular carcinoma cells. Cancer Letters, 292, 197-207.
5. Li, X., Jiao, L.L., Zhang, X., Tian, W.M., Chen, S., & Zhang, L.P. (2008). Anti-tumor and immunomodulating activities of proteoglycans from mycelium of Phellinus nigricans and culture medium. International Immunopharmacology, 8, 909-915.
6. Liu, H., Bungener, L., Veer, W.T., Coller, B.A., Wilschut, J., & Huckriede, A. (2011). Preclinical evaluation of the saponin derivative GPI-0100 as an immunostimulating and dose-sparing adjuvant for pandemic influenza vaccines. Vaccine, 29, 2037-2043.
7. Man, S.L., Gao, W.Y., Zhang, Y.J., Huang, L.Q., & Liu, C.X. (2010). Chemical study and medical application of saponins as anti-cancer agents. Fitoterapia, 81, 703-714.
8. Moalic, S., Liagre, B., Corbiè re, C., Bianchi, A., Dauç a, M., Bordji, K., & Beneytout, J.L. (2001). A plant steroid, diosgenin, induces apoptosis, cell cycle arrest and COX activity in osteosarcoma cells. FEBS Letters, 506, 225-230. (Pubitemid 32964818)
9. Raju, J., & Mehta, R. (2009). Cancer chemopreventive and therapeutic effects of diosgenin, a food saponin. Nutrition and Cancer, 61, 27-35.
10. Wang, J., Zu, X.Y., & Jiang, Y.Y. (2009). Five furostanol saponins from fruits of Tribulus terrestris and their cytotoxic activities. Natural Product Research, 23, 1436-1444.
11. Xie, Y., Deng, W., Sun, H., & Li, D. (2008). Platycodin D2 is a potential less hemolytic saponin adjuvant eliciting Th1 and Th2 immune responses. International Immunopharmacology, 8, 1143-1150.